Assessing the risk of laboratory-acquired meningococcal disease

Journal of Clinical Microbiology

Volumn 43, Issue 9, 2005, Pages 4811-4814

  Sejvar, James J ^a   Johnson, David ^b   Popovic, Tanja ^c   Miller, J Michael ^c   Downes, Frances ^b   Somsel, Patricia ^b   Weyant, Robbin ^d   Stephens, David S ^c   Perkins, Bradley A ^c   Rosenstein, Nancy E ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROSOL; ARTICLE; BACTERIUM ISOLATE; BIOSAFETY; FEMALE; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LABORATORY; MALE; MENINGOCOCCOSIS; MICROBIOLOGY; NEISSERIA MENINGITIDIS; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; RISK ASSESSMENT; SEROTYPE; UNITED STATES;

ADULT; AGED; FEMALE; HUMANS; LABORATORIES; LABORATORY INFECTION; LABORATORY PERSONNEL; MALE; MENINGOCOCCAL INFECTIONS; MICROBIOLOGY; MIDDLE AGED; NEISSERIA MENINGITIDIS, SEROGROUP B; NEISSERIA MENINGITIDIS, SEROGROUP C; OCCUPATIONAL EXPOSURE; RISK FACTORS;

NEISSERIA MENINGITIDIS;

EID: 24744456120     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.9.4811-4814.2005     Document Type: Article

References (20)

1. Anonymous. 1936. Bacteriologist dies of meningitis: death attributable to meningitis contracted while conducting experiments in the laboratory. JAMA 106:109.
2. Berg, S., B. Trollfors, K. Alestig, and U. Jodal. 1992. Incidence, serogroups, and case-fatality rate of invasive meningococcal infections in a Swedish region, 1975-1989. Scand. J. Infect. Dis. 24:333-338.
3. Bhatti, A. R., V. L. DiNinno, F. E. Ashton, and L. A. White. 1982. A laboratory-acquired infection with Neisseria meningitidis. J. Infect. 4:247-252.
4. Boutet, R., J. M. Stuart, E. B. Kaczmarski, et al. 2001. Risk of laboratory-acquired meningococcal disease. J. Hosp. Infect. 49:282-284.
5. Centers for Disease Control and Prevention. 2002. Laboratory-acquired meningococcal disease-United States. 2000. Morb. Mortal. Wkly. Rep. 51:141-144.
6. Centers for Disease Control and Prevention. 1997. Case definitions for infectious conditions under public health surveillance. Morb. Mortal. Wkly. Rep. 46(RR-10):24.
7. Centers for Disease Control and Prevention. 2003. Summary of notifiable diseases, 2001. Morb. Mortal. Wkly. Rep. 53:15.
8. Centers for Disease Control and Prevention. 1999. Biosafety in microbiological and biomedical laboratories, 4th ed. Centers for Disease Control and Prevention, Atlanta, Ga.
9. Centers for Disease Control and Prevention. 1991. Laboratory-acquired meningococcemia-California and Massachusetts. Morb. Mortal. Wkly. Rep. 40:45-55.
10. Centers for Disease Control and Prevention. 2000. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 49(RR-07):1-10.
11. Centers for Disease Control and Prevention. 2005. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 54(RR-7):19-20.
12. Collins, C. H., and D. Kennedy. 1999. Laboratory-acquired infections: history, incidence, causes, and preventions, 4th ed., p. 65-110. Butterworth-Heinemann, Oxford, United Kingdom.
13. Guibourdenche, M., J.-P. Darchis, A. Boisivon, E. Collatz, and J-Y. Riou. 1994. Enzyme electrophoresis, sero- and subtyping, and outer membrane protein characterization of two Neisseria meningitidis strains involved in laboratory-acquired infections. J. Clin. Microbiol. 32:701-704.
14. National Committee for Clinical Laboratory Standards. 2001. Protection of laboratory workers from occupationally acquired infections. Approved guideline M29-A2, 2nd ed., p. 12-13. National Committee for Clinical Laboratory Standards, Wayne, Pa.
15. Paradis, J., and D. Grimard. 1994. Laboratory-acquired invasive meningococcus-Quebec. Can. Commun. Dis. Rep. 20:124.
16. PHLS Communicable Disease Surveillance Center. 1992. Laboratory-acquired meningococcal infection. Commun. Dis. Rep. 2:39.
17. Pike, R. M. 1979. Laboratory-associated infections: incidence, fatalities, causes, and prevention. Annu. Rev. Microbiol. 33:41-66.
18. Rosenstein, N. E., B. A. Perkins, D. S. Stephens, et al. 1999. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J. Infect. Dis. 180:1894-1901.
19. Rosenstein, N. E., M. Fischer, and J. W. Tappero. 2001. Meningococcal vaccines. Infect. Dis. Clin. N. Am. 15:155-169.
20. Wilson, N., et al. 1995. Meningococcal disease epidemiology and control in New Zealand. N. Z. Med. J. 108:437-442.